A novel therapy option for heart failure with dual angiotensin receptor and neprilysin inhibition
Liu, X.; Hong, K.
Zhonghua Xin Xue Guan Bing Za Zhi 43(12): 1025-1027
2015
ISSN/ISBN: 0253-3758 PMID: 26888834 Document Number: 681931
Document emailed within 1 workday
Related Documents
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149Kobalava, Z.D.; Pavlikova, E.P.; Averkov, O.A.; Merai, I.; Babaeva, L.A.; Amirbegishvili, I.M.; Kotovskaya, Y.V.; Moisfev, V.S. 2015: First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients with Chronic Heart Failure and Reduced Ejection Fraction Kardiologiia 55(7): 14-25
Russo-Vorms, L.; Meyer, P.; Reny, J.-L. 2019: « ARNI » (Angiotensin Receptor-Neprilysin Inhibitor): when, for whom and how? Revue Medicale Suisse 15(667): 1882-1886
Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159
Bonarjee, V.V.; Dickstein, K. 2000: Use of angiotensin Ii receptor blockaders in heart failure Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(7): 817-821
2002: Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor MMW Fortschritte der Medizin 144(40): 49
Levine, T.B. 1989: Effect of angiotensin converting enzyme inhibition on renal function in the treatment of heart failure Clinical Therapeutics 11(4): 495-502
Huang, J. 2006: The important role of angiotensin receptor blocker on treatment of chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(9): 773-774
Tao, Z-wei.; Huang, Y-wei.; Xia, Q.; Xu, Q-wen. 2005: Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction Chinese Medical Journal 118(2): 146-154
de la Fuente Cid, R.; Varela Román, A. 2007: Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure? Anales de Medicina Interna 24(12): 607-609
Spinale, F.G.; Holzgrefe, H.H.; Mukherjee, R.; Webb, M.L.; Hird, R.B.; Cavallo, M.J.; Powell, J.R.; Koster, W.H. 1997: Angiotensin-converting enzyme inhibition and angiotensin Ii subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes Journal of Pharmacology and Experimental Therapeutics 283(3): 1082-1094
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Gabrusenko, S.A.; Naumov, V.G.; Krasnikova, T.L.; Kupriianenko, T.I.; Gadzhiev, A.B.; Mazaev, A.V.; Mukharliamov, N.M. 1990: Cellular beta-adrenergic receptor complex in patients with heart failure and its changes during digoxin therapy Kardiologiia 30(7): 67-72
Hunyady, L.; Nagy, L. 1997: AT1 angiotensin receptor inhibition as a new therapeutic possibility Orvosi Hetilap 138(41): 2583-2590
Messerli, F.H.; Weber, M.A.; Brunner, H.R. 1996: Angiotensin II receptor inhibition. A new therapeutic principle Archives of Internal Medicine 156(17): 1957-1965
Corbalán, R.; Kunstmann, S.; Jalil, J. 1993: Vasodilator agents in chronic heart failure: which is the best option? Revista Medica de Chile 121(1): 81-88
Hayward, M.P.; Cumming, D.V.; Pattison, C.W. 1995: Myoplasty--a surgical option for end-stage heart failure British Journal of Hospital Medicine 53(9): 435-438